Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Generalised anxiety disorder

Recruiting

Investigational

Study on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Iti-1284

Contact Research Centre

Cardiac failure

Recruiting

Registered drug

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Bi 690517

Contact Research Centre

Acute myocardial infarction

Recruiting

Investigational

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Selatogrel

Contact Research Centre

Tardive dyskinesia

Recruiting

Investigational

Efficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia

Investigational

Bulgaria

Participants:18–64 years · 65+ years

Contact Research Centre

Systemic lupus erythematosus+3

Recruiting

Investigational

A Phase 3 Study of Enpatoran to Treat Active Cutaneous Lupus in Patients With or Without Systemic Disease

Investigational

Bulgaria

Participants:18–64 years · 65+ years

Contact Research Centre

Major depression

Recruiting

InvestigationalNo placebo

Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE

Contact Research Centre

Cardiac failure

Recruiting

Registered drug

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Bi 690517

Contact Research Centre

Major depression

Recruiting

Investigational

Assessment of NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE

Contact Research Centre

Major depression

Recruiting

Investigational

Study of milsaperidone as an additional treatment for adults with Major Depressive Disorder who are already taking antidepressants

Investigational

Bulgaria

Participants:18–64 years
Substances:(1S)-1-[4-[3-[4-(6-FLUORO-1,2-BENZOXAZOL-3-YL)PIPERIDIN-1-YL]PROPOXY]-3-METHOXYPHENYL]ETHANOL

Contact Research Centre

Major depression

Recruiting

Investigational

Study on Lumateperone for Patients with Major Depressive Disorder Not Responding to Antidepressants

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Lumateperone

Contact Research Centre

Dementia Alzheimer's type

Recruiting

InvestigationalNo placebo

Long-Term Safety Study of ACP-204 for Adults with Alzheimer's Disease Psychosis

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Acp-204 Tartrate

Contact Research Centre

Obesity+2

Not yet recruiting

Investigational

Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease

Investigational

Bulgaria

Participants:18–64 years

Contact Research Centre

Find therapies in clinical trials near you

27 trials match your criteria

Generalised anxiety disorder

Study on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments

Cardiac failure

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Acute myocardial infarction

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Tardive dyskinesia

Efficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia

Systemic lupus erythematosus+3

A Phase 3 Study of Enpatoran to Treat Active Cutaneous Lupus in Patients With or Without Systemic Disease

Major depression

Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

Cardiac failure

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Major depression

Assessment of NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder

Major depression

Study of milsaperidone as an additional treatment for adults with Major Depressive Disorder who are already taking antidepressants

Major depression

Study on Lumateperone for Patients with Major Depressive Disorder Not Responding to Antidepressants

Dementia Alzheimer's type

Long-Term Safety Study of ACP-204 for Adults with Alzheimer's Disease Psychosis

Obesity+2

Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.